What We're Reading: Page 275
Industry reads hand-picked by our editors
Oct 26, 2017
-
Bloomberg
The wonder drug for aging (made from one of the deadliest toxins on Earth)
-
Vox
2 new CRISPR tools overcome the scariest parts of gene editing
-
Boston Business Journal
MGH researcher develops promising Alzheimer's drug
-
Gizmodo
When hope runs out, cancer patients are making their own DIY immunotherapy treatments
Oct 25, 2017
-
Retail Dive
Walgreens sales remain 'anemic' despite Rite Aid takeover
-
MIT Technology Review
Tracking the cost of gene therapy
-
MobiHealthNews
Bracket acquires mProve Health, doubles-down on mobile-supported clinical trials
-
Technology Networks
The role of phenotypic screening in drug discovery
Oct 24, 2017
Oct 23, 2017
-
Reuters
AstraZeneca among backers as Swiss cancer biotech raises $200 million
-
The Wall Street Journal
The business of saving lives
-
Toledo Blade
Californians pushing ballot initiatives in Ohio
Oct 20, 2017
-
NEJM Catalyst
Reframing the conversation on drug pricing
-
The Wall Street Journal
Hacking is a risk for pacemakers. So is the fix
-
Bloomberg
No one values your life more than the federal government
Previous
